BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11721619)

  • 1. Hot topics in adeno-associated virus as a gene transfer vector.
    Zhao N; Liu DP; Liang CC
    Mol Biotechnol; 2001 Nov; 19(3):229-37. PubMed ID: 11721619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus-based vectors in gene therapy.
    Tal J
    J Biomed Sci; 2000; 7(4):279-91. PubMed ID: 10895050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector.
    Liu Q; Perez CF; Wang Y
    J Virol; 2006 Feb; 80(4):1672-9. PubMed ID: 16439524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
    Dong JY; Fan PD; Frizzell RA
    Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.
    Costantini LC; Jacoby DR; Wang S; Fraefel C; Breakefield XO; Isacson O
    Hum Gene Ther; 1999 Oct; 10(15):2481-94. PubMed ID: 10543613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
    Fan PD; Dong JY
    Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy: recombinant adeno-associated virus vectors.
    Smith-Arica JR; Bartlett JS
    Curr Cardiol Rep; 2001 Jan; 3(1):43-9. PubMed ID: 11139798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.
    Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y
    Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the use of adeno-associated viral vectors for gene therapy.
    Büning H; Braun-Falco M; Hallek M
    Cells Tissues Organs; 2004; 177(3):139-50. PubMed ID: 15388988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in recombinant adeno-associated virus vector production.
    Clark KR
    Kidney Int; 2002 Jan; 61(1 Suppl):S9-15. PubMed ID: 11841606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated viral vectors as gene delivery vehicles.
    Carter PJ; Samulski RJ
    Int J Mol Med; 2000 Jul; 6(1):17-27. PubMed ID: 10851261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.
    Maurer AC; Weitzman MD
    Hum Gene Ther; 2020 May; 31(9-10):499-511. PubMed ID: 32303138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer by adeno-associated virus vectors into the central nervous system.
    Xiao X; Li J; McCown TJ; Samulski RJ
    Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.